BeOne Medicines
Martin Dobson is an experienced commercial leader in the biopharmaceutical industry, currently serving as Senior Director Commercial CEEG at BeiGene since December 2022. Dobson previously held roles at Jazz Pharmaceuticals as Business Director International and Partner Markets, where responsibilities included expanding the Haematology portfolio and securing reimbursement in Central Eastern Europe and Greece. Prior to that, Dobson worked at Celgene as Account Director and Partner Liaison Director, focusing on strategic delivery and operational management of key Distributor Partner relationships. Earlier experience includes serving as EU Distributor Markets Director and Head of Distribution and Pharmacy at Bristol-Myers Squibb, where Dobson developed relationships with distributors and managed product availability in multiple regions. Dobson's career began at DuPont Pharmaceuticals, encompassing various sales and managerial roles. Dobson holds a B.Sc in Food Science and Management Studies from King's College London.
This person is not in any teams
This person is not in any offices
BeOne Medicines
34 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.